Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | SLC22A12 | Q96S37 | 3/20 | 0.39 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | TYMS | P04818 | 1/20 | 0.37 |
| ▸ | XDH | P47989 | 1/20 | 0.37 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.37 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.37 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29362932 | 1.00 | CYP1A2 (0.45) | CYP1A2KDM4EALDH1A1GAAMAPT | |
| SCHEMBL4256378 | 0.92 | CYP1A2 (0.38) | CYP1A2KDM4EALDH1A1GAAMAPT | |
| SCHEMBL3285789 | 0.88 | CYP1A2 (0.45) | CYP1A2KDM4EALDH1A1GAAMAPT | |
| SCHEMBL4409157 | 0.86 | ALDH1A1 (0.41) | KDM4EALDH1A1GAAMAPTSLC22A12 | |
| SCHEMBL29958304 | 0.84 | CYP1A2 (0.48) | CYP1A2SLC22A12XDH | |
| SCHEMBL7042791 | 0.84 | CYP1A2 (0.48) | CYP1A2SLC22A12XDH | |
| SCHEMBL20506657 | 0.84 | CYP1A2 (0.48) | CYP1A2SLC22A12XDH | |
| SCHEMBL29958368 | 0.84 | CYP1A2 (0.48) | CYP1A2SLC22A12XDH | |
| SCHEMBL2173708 | 0.81 | CYP1A2 (0.58) | CYP1A2KDM4EALDH1A1MAPTPARP1 | |
| SCHEMBL10620743 | 0.80 | KDM4E (0.57) | KDM4EALDH1A1GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016046779-A1 | ZINC POLYAZAMACROCYCLIC COMPLEXES | ENI S.P.A. (IT) | 2016-03-31 | — | — | WO | claimed |
| EP-1542975-B1 | 9-CYANO-SUBSTITUTED PERYLENE-3,4-DICARBOXYLIC ACID MONOIMIDES | BASF SE (DE) | 2016-03-09 | — | — | EP | claimed |
| US-7446198-B2 | 9-Cyano-substituted perylene-3, 4-dicarboxylic monoimides | BASF AKTIENGESELLSCHAFT (DE) | 2008-11-04 | — | — | US | claimed |
| US-20060229385-A1 | 9-Cyano-Substituted Perylene-3, 4-Dicarboxylic Monoimides | BASF AKTIENGESELLSCHAFT (DE) | 2006-10-12 | — | — | US | claimed |
| WO-2016046779-A1 | ZINC POLYAZAMACROCYCLIC COMPLEXES | ENI S.P.A. (IT) | 2016-03-31 | — | — | WO | disclosed |
| US-7550606-B2 | 9-cyano-substituted perylene-3,4-dicarboxylic acid monoimides | BASF AKTIENGESELLSCHAFT (DE) | 2009-06-23 | — | — | US | disclosed |
| US-20090023937-A1 | 9-CYANO-SUBSTITUTED PERYLENE-3,4-DICARBOXYLIC ACID MONOIMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2009-01-22 | — | — | US | disclosed |
| US-7446198-B2 | 9-Cyano-substituted perylene-3, 4-dicarboxylic monoimides | BASF AKTIENGESELLSCHAFT (DE) | 2008-11-04 | — | — | US | disclosed |
| US-20060229385-A1 | 9-Cyano-Substituted Perylene-3, 4-Dicarboxylic Monoimides | BASF AKTIENGESELLSCHAFT (DE) | 2006-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023937-A1 | 9-CYANO-SUBSTITUTED PERYLENE-3,4-DICARBOXYLIC ACID MONOIMIDES | CA9, F9, CA13 | CYP1A2 800/4885KDM4E 625/4885ALDH1A1 1588/4885 |
| US-20060229385-A1 | 9-Cyano-Substituted Perylene-3, 4-Dicarboxylic Monoimides | CBR3, NR2C2, NR0B2 | CYP1A2 607/4885KDM4E 2927/4885ALDH1A1 3964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.